Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
12.83
+0.29 (2.31%)
Apr 13, 2026, 4:00 PM EDT - Market closed
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $4.09 billion as of April 14, 2026. Its market cap has increased by 56.22% in one year.
Market Cap
4.09B
Enterprise Value
6.50B
1-Year Change
56.22%
Ranking
Category
Stock Price
$12.83
Market Cap Chart
Since May 7, 2018, Amneal Pharmaceuticals's market cap has increased from $1.91B to $4.09B, an increase of 114.66%. That is a compound annual growth rate of 10.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 4.00B | 0.99% |
| Dec 31, 2025 | 3.96B | 61.41% |
| Dec 31, 2024 | 2.45B | 31.88% |
| Dec 29, 2023 | 1.86B | 517.28% |
| Dec 30, 2022 | 301.44M | -57.87% |
| Dec 31, 2021 | 715.49M | 6.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkermes | 5.55B |
| Lantheus Holdings | 5.24B |
| Hims & Hers Health | 4.43B |
| Kiniksa Pharmaceuticals International, | 3.60B |
| Liquidia | 3.40B |
| Supernus Pharmaceuticals | 2.92B |
| Prestige Consumer Healthcare | 2.68B |
| HUTCHMED (China) | 2.55B |